US Starts Section 301 Probe of Germany Over Pharmaceuticals
Source:
bloombergMarkets
June 18, 2026 · 17:33
The US has begun a fresh tariff investigation into Germany over what it called “persistent underpayment for innovative pharmaceutical products,” setting the stage for levies on its goods in retaliation.
The original article opens on the publisher's website.
More from General
View topic →Japanese green tea giant Ito En surges 8%, defying a broad market sell-off
cnbc
Sep 1, 2026 · 19:24
Australia posts second-quarter growth of 2.1%, beating expectations
cnbc
Sep 1, 2026 · 18:47
Fake 10 Downing Street listing exposes 'unfit' Booking.com, says consumer group
bbcTechnology
Sep 1, 2026 · 18:27
Massachusetts’ 80-year-old senator sees off primary challenge over his age
financialTimes
Sep 1, 2026 · 18:06
Pentagon chaos deepens after Driscoll quits in clash with Hegseth
financialTimes
Sep 1, 2026 · 17:47
Countries mentioned